Results 221 to 230 of about 62,107 (256)

Pathogenesis of Ankylosing Spondylitis — Recent Advances and Future Directions

Nature Reviews Rheumatology, 2017
Robert D. Inman, Matthew A. Brown, Eric Gracey   +2 more
exaly  

Human medicines European public assessment report (EPAR): Zessly, infliximab, Arthritis, Psoriatic,Psoriasis,Crohn Disease,Arthritis, Rheumatoid,Colitis, Ulcerative,Spondylitis, Ankylosing, Date of authorisation: 18/05/2018, Revision: 3, Status: Authorised

Case Medical Research, 2019
openaire   +1 more source

Efficacy and Safety of Upadacitinib in Patients With Active Ankylosing Spondylitis (SELECT-AXIS 1): A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Phase 2/3 Trial

Lancet, The, 2019
Walter P Maksymowych, Atul Deodhar, Tae-Hwan Kim   +2 more
exaly  

Human medicines European public assessment report (EPAR): Remsima, infliximab, Arthritis, Psoriatic,Spondylitis, Ankylosing,Colitis, Ulcerative,Psoriasis,Crohn Disease,Arthritis, Rheumatoid, Date of authorisation: 10/09/2013, Revision: 16, Status: Authorised

Case Medical Research, 2019
openaire   +1 more source

TNFAIP3-DEPTOR Complex Regulates Inflammasome Secretion Through Autophagy in Ankylosing Spondylitis Monocytes

Autophagy, 2018
Fenyong Liu, Huanyu Lu, Ping Zhu
exaly  

Human medicines European public assessment report (EPAR): Remsima, infliximab, Arthritis, Psoriatic,Spondylitis, Ankylosing,Colitis, Ulcerative,Psoriasis,Crohn Disease,Arthritis, Rheumatoid, Date of authorisation: 10/09/2013, Revision: 15, Status: Authorised

Case Medical Research, 2019
openaire   +1 more source

Efficacy and Safety of Filgotinib, a Selective Janus Kinase 1 Inhibitor, in Patients With Active Ankylosing Spondylitis (TORTUGA): Results From a Randomised, Placebo-Controlled, Phase 2 Trial

Lancet, The, 2018
Lianne S Gensler, Robert Landewé, Walter P Maksymowych   +2 more
exaly  

Human medicines European public assessment report (EPAR): Inflectra, infliximab, Arthritis, Psoriatic,Spondylitis, Ankylosing,Colitis, Ulcerative,Psoriasis,Crohn Disease,Arthritis, Rheumatoid, Date of authorisation: 09/09/2013, Revision: 20, Status: Authorised

Case Medical Research, 2019
openaire   +1 more source

IL-17A blockade ameliorates ankylosing spondylitis

Nature Reviews Rheumatology, 2016
João H. Duarte
exaly  

Human medicines European public assessment report (EPAR): Remicade, infliximab, Spondylitis, Ankylosing,Arthritis, Rheumatoid,Psoriasis,Crohn Disease,Arthritis, Psoriatic,Colitis, Ulcerative, Date of authorisation: 13/08/1999, Revision: 54, Status: Authorised

Case Medical Research, 2019
openaire   +1 more source